Key facts
- Nerveli’s last known valuation is $2.0M (Sep 2024).
- It has raised $1.1M across 1 recorded rounds; the latest was Seed Round ($430K) in Sep 2025.
- Notable investors include Techstars, MassChallenge, 2 the Moon, DFW Angels, Dean Jacobson — 10 tracked in total.
- Nerveli has filed 1 Form D with the SEC, most recently Sep 2025 ($430K sold to 1 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 10 names
- ·Watchlist + deal alerts for Nerveli
Funding rounds
1 roundsAbout Nerveli
Developer of a pain management app designed to understand and manage chronic aching through personalized and evidence-based approaches. The company offers symptom tracking, behavioral therapy, educational content, and data-driven insights through a mobile application, enabling health insurers, employers, and healthcare providers to assist individuals and employees in gaining better control over their pain, reducing stress, and improving overall well-being.
- Sector
- Healthcare
- HQ
- Dallas, TX, United States
- Founded
- 2022
- Employees
- 7
- Website
- getnerveli.com/
- Ownership
- Privately Held (backing)
Nerveli doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Nerveli shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Nerveli in its N-PORT filings yet. We sweep new filings monthly.